← FDA DRUG APPROVALS

FDA ANDA · ANDA040257

OXYCODONE AND ACETAMINOPHEN

Sponsor: MALLINCKRODT

APPLICATION
ANDA040257
TYPE
ANDA
ORIGINAL APPROVAL
1998-08-04
LATEST ACTION
1999-10-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

OXYCODONE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG, OXYCODONE HYDROCHLORIDE 5MG · CAPSULE · ORAL

Approval history

1999-10-07Manufacturing (CMC) · Supplement 1AP
1998-08-04OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →